Kyoto, Japan

Eri Mizuhara

USPTO Granted Patents = 3 


 

Average Co-Inventor Count = 4.5

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Kyoto, JP (2009 - 2011)
  • Hyogo, JP (2013)

Company Filing History:


Years Active: 2009-2013

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Eri Mizuhara: Innovator in Neurobiology

Introduction

Eri Mizuhara is a prominent inventor based in Kyoto, Japan. He has made significant contributions to the field of neurobiology, particularly in the identification and isolation of GABA neuron progenitor cells. His innovative work has led to the development of several patents that are crucial for advancing research in neurodegenerative diseases.

Latest Patents

Mizuhara holds 3 patents, with his latest inventions focusing on GABA neuron progenitor cells. One of his notable patents is the identification of a selective marker, 65B13, for GABA neuron progenitor cells in the spinal dorsal horn and cerebellum. This marker has proven to be useful in isolating GABA-producing neuron progenitor cells, allowing for more efficient identification and isolation processes. Another significant patent involves a novel gene, also named 65B13, which is specifically expressed in postmitotic dopaminergic neuron precursor cells. This gene can serve as an index for selecting cells that are suitable for transplant therapy in neurodegenerative diseases, such as Parkinson's disease.

Career Highlights

Eri Mizuhara is currently associated with Eisai R&D Management Co., Ltd., where he continues to push the boundaries of neurobiological research. His work has garnered attention for its potential applications in therapeutic strategies for various neurological conditions.

Collaborations

Mizuhara collaborates with esteemed colleagues, including Yasuko Nakagawa and Yuichi Ono, who contribute to his research endeavors. Their combined expertise enhances the innovative potential of their projects.

Conclusion

Eri Mizuhara's contributions to neurobiology through his patents and research are paving the way for advancements in the treatment of neurodegenerative diseases. His work exemplifies the impact of innovation in the scientific community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…